Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jeffrey Petty

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
JAMA Oncology|December 15, 2022
Emerging Strategies for the Treatment of Small Cell Lung Cancer: A ReviewW Jeffrey Petty, Luis Paz-Ares
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Cyclin D1 as a target for chemopreventionW Jeffrey Petty, Konstantin H Dragnev, Ethan Dmitrovsky
Cancer Biology & Therapy|September 26, 2003
Retinoid targets in cancer therapy and chemopreventionKonstantin H Dragnev, W Jeffrey Petty, Ethan Dmitrovsky
Lung Cancer (Amsterdam, Netherlands)|September 19, 2009
Using erlotinib to treat patients with non-small cell lung cancer who continue to smokeLynsay L Waller, Antonius A Miller, W Jeffrey Petty
Endocrine, Metabolic & Immune Disorders Drug Targets|April 9, 2008
Distinct functions of retinoic acid receptor beta isoforms: implications for targeted therapyCatherine B Swift, John L Hays, W Jeffrey Petty
Oncotarget|November 29, 2016
Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancerYunping Hu, Xin Feng, Akiva Mintz, et al.
Clinical Lung Cancer|January 15, 2004
The role of docetaxel in nonplatinum-based combination chemotherapy for non-small-cell lung cancerW Jeffrey Petty, Joerg Rothmann, Konstantin H Dragnev, et al.
Expert Review of Anticancer Therapy|October 15, 2010
Effects of continued tobacco use during treatment of lung cancerLynsay L Waller, Kathryn E Weaver, W Jeffrey Petty, et al.
Clinical Lung Cancer|February 8, 2005
Nonclassical retinoids and lung carcinogenesisKonstantin H Dragnev, W Jeffrey Petty, Yan Ma, et al.
Sarcoma|November 30, 2016
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic SarcomaPaul D Savage, James Lovato, K Bridget Brosnihan, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
JAMA Oncology|December 15, 2022
Emerging Strategies for the Treatment of Small Cell Lung Cancer: A ReviewW Jeffrey Petty, Luis Paz-Ares
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Cyclin D1 as a target for chemopreventionW Jeffrey Petty, Konstantin H Dragnev, Ethan Dmitrovsky
Cancer Biology & Therapy|September 26, 2003
Retinoid targets in cancer therapy and chemopreventionKonstantin H Dragnev, W Jeffrey Petty, Ethan Dmitrovsky
Lung Cancer (Amsterdam, Netherlands)|September 19, 2009
Using erlotinib to treat patients with non-small cell lung cancer who continue to smokeLynsay L Waller, Antonius A Miller, W Jeffrey Petty
Endocrine, Metabolic & Immune Disorders Drug Targets|April 9, 2008
Distinct functions of retinoic acid receptor beta isoforms: implications for targeted therapyCatherine B Swift, John L Hays, W Jeffrey Petty
Oncotarget|November 29, 2016
Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancerYunping Hu, Xin Feng, Akiva Mintz, et al.
Clinical Lung Cancer|January 15, 2004
The role of docetaxel in nonplatinum-based combination chemotherapy for non-small-cell lung cancerW Jeffrey Petty, Joerg Rothmann, Konstantin H Dragnev, et al.
Expert Review of Anticancer Therapy|October 15, 2010
Effects of continued tobacco use during treatment of lung cancerLynsay L Waller, Kathryn E Weaver, W Jeffrey Petty, et al.
Clinical Lung Cancer|February 8, 2005
Nonclassical retinoids and lung carcinogenesisKonstantin H Dragnev, W Jeffrey Petty, Yan Ma, et al.
Sarcoma|November 30, 2016
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic SarcomaPaul D Savage, James Lovato, K Bridget Brosnihan, et al.
Pageof 6